verapamil has been researched along with Prostatic Hyperplasia in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tamsulosin is an alpha1-adrenoceptor antagonist for the treatment of symptomatic benign prostatic hyperplasia with a tolerability similar to that of placebo in short-term, placebo-controlled studies with limited patient numbers." | 5.09 | A 6-month large-scale study into the safety of tamsulosin. ( Bressel, HU; Goepel, M; Michel, MC; Rübben, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, SCH | 1 |
| Cho, C | 1 |
| Hung, E | 1 |
| Wang, D | 1 |
| Chiu, P | 1 |
| Yee, CH | 1 |
| Ng, A | 1 |
| Michel, MC | 1 |
| Bressel, HU | 1 |
| Goepel, M | 1 |
| Rübben, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial Comparing Water Vapour Thermal Therapy (Rezūm) and TURP in Men With Benign Prostatic Hyperplasia in Refractory Urinary Retention[NCT05762198] | 108 participants (Anticipated) | Interventional | 2023-05-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for verapamil and Prostatic Hyperplasia
| Article | Year |
|---|---|
A 6-month large-scale study into the safety of tamsulosin.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug | 2001 |
1 other study available for verapamil and Prostatic Hyperplasia
| Article | Year |
|---|---|
Case-Control Study of Intra-arterial Verapamil for Intraprostatic Anastomoses to Extraprostatic Arteries in Prostatic Artery Embolization for Benign Prostatic Hypertrophy.
Topics: Aged; Angiography; Case-Control Studies; Embolization, Therapeutic; Humans; Injections, Intra-Arteri | 2017 |